Literature DB >> 20735433

The side population, as a precursor of Hodgkin and Reed-Sternberg cells and a target for nuclear factor-κB inhibitors in Hodgkin's lymphoma.

Makoto Nakashima1, Yumiko Ishii, Mariko Watanabe, Tomiteru Togano, Kazuo Umezawa, Masaaki Higashihara, Toshiki Watanabe, Ryouichi Horie.   

Abstract

Although disturbed cytokinesis of mononuclear Hodgkin (H) cells is thought to generate Reed-Sternberg (RS) cells, differentiation of Hodgkin's lymphoma (HL) cells is not fully understood. Recent studies indicate that cells found in a side population (SP) share characteristics of cancer stem cells. In this study we identified an SP in the HL cell lines, KMH2 and L428. This SP almost entirely consists of distinct small mononuclear cells, whereas the non-SP is a mixture of relatively large cells with H or RS cell-like morphology. Culture of the small mononuclear cells in the SP from KMH2 generated a non-SP. Single cell culture of the SP cells generated large cells with H or RS cell-like morphology. We found that CD30 overexpression and constitutive nuclear factor-κB (NF-κB) activity, both of which are characteristics of HL cells, are shared between the SP and non-SP cells for both KMH2 and L428. Inhibition of NF-κB induced apoptosis in both fractions, whereas the SP cells were resistant to a conventional chemotherapeutic agent doxorubicin. The results show that HL cell lines contain an SP, that is enriched for distinct small mononuclear cells and generates larger cells with H and RS cell-like morphology. The results also stress the significance of NF-κB inhibition for eradication of HL cells.
© 2010 Japanese Cancer Association.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20735433     DOI: 10.1111/j.1349-7006.2010.01693.x

Source DB:  PubMed          Journal:  Cancer Sci        ISSN: 1347-9032            Impact factor:   6.716


  8 in total

Review 1.  Hodgkin lymphoma.

Authors:  Ralf Küppers; Andreas Engert; Martin-Leo Hansmann
Journal:  J Clin Invest       Date:  2012-10-01       Impact factor: 14.808

2.  ID1 upregulation and FoxO3a downregulation by Epstein-Barr virus-encoded LMP1 in Hodgkin's lymphoma.

Authors:  Jun-Ichiro Ikeda; Naoki Wada; Satoshi Nojima; Shinichiro Tahara; Yoko Tsuruta; Kaori Oya; Eiichi Morii
Journal:  Mol Clin Oncol       Date:  2016-09-08

3.  Lymphoma stem cells: A step toward a new therapeutic target.

Authors:  Seok Jin Kim
Journal:  Korean J Hematol       Date:  2011-12-27

4.  Small and big Hodgkin-Reed-Sternberg cells of Hodgkin lymphoma cell lines L-428 and L-1236 lack consistent differences in gene expression profiles and are capable to reconstitute each other.

Authors:  Benjamin Rengstl; Sooji Kim; Claudia Döring; Christian Weiser; Julia Bein; Katrin Bankov; Marco Herling; Sebastian Newrzela; Martin-Leo Hansmann; Sylvia Hartmann
Journal:  PLoS One       Date:  2017-05-15       Impact factor: 3.240

Review 5.  Genomic Landscape of Hodgkin Lymphoma.

Authors:  Magdalena M Brune; Darius Juskevicius; Jasmin Haslbauer; Stefan Dirnhofer; Alexandar Tzankov
Journal:  Cancers (Basel)       Date:  2021-02-08       Impact factor: 6.639

6.  A Multi-Component Model of Hodgkin's Lymphoma.

Authors:  Martin S Staege
Journal:  PLoS One       Date:  2015-04-27       Impact factor: 3.240

7.  Cancer stem cells of differentiated B-cell malignancies: models and consequences.

Authors:  Emilie Gross; Anne Quillet-Mary; Loic Ysebaert; Guy Laurent; Jean-Jacques Fournie
Journal:  Cancers (Basel)       Date:  2011-03-25       Impact factor: 6.639

8.  Isolation and characterization of a CD34+ sub-clone in B-cell lymphoma.

Authors:  Ayad M Al-Katib; Abdul Shukkur Ebrahim; Mustapha Kandouz; Feras Zaiem; Ali Raufi; Salah Ebrahim; Anwar Mohamed; Nada Emara; Ali M Gabali
Journal:  Oncotarget       Date:  2020-01-14
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.